Search research articles
Contact Us
Filters
Showing results (31-40 of 125) with videos related to
Page
of 13
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
July 16, 2010
Activation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor β2 in cancer cells
Youzhong Wan, Maojing Yang, Sunny Kolattukudy, et al.
The Journal of Biological Chemistry
|
November 4, 2004
Role of tyrosine 441 of interferon-gamma receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation
Yulan Qing, Ana P Costa-Pereira, Diane Watling, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 20, 2021
PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance to DNA damage
HyeonJoo Cheon, Elise G Holvey-Bates, Daniel J McGrail, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2002
IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA
Kristi L Peters, Heather L Smith, George R Stark, et al.
Trends in Immunology
|
April 4, 2002
Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling
Chilakamarti V Ramana, M Pilar Gil, Robert D Schreiber, et al.
Cancer Research
|
October 19, 2007
p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21
Charlene E Kan, John T Patton, George R Stark, et al.
Immunity
|
September 19, 2006
Complex modulation of cell type-specific signaling in response to type I interferons
Anette H H van Boxel-Dezaire, M R Sandhya Rani, George R Stark
Trends in Cancer
|
October 10, 2022
How cancer cells make and respond to interferon-I
HyeonJoo Cheon, Yuxin Wang, Samantha M Wightman, et al.
The EMBO Journal
|
November 18, 2016
Negative regulation of type I IFN signaling by phosphorylation of STAT2 on T387
Yuxin Wang, Jing Nan, Belinda Willard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2021
The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage
Sarmishtha De, Elise G Holvey-Bates, Kala Mahen, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 125) with videos related to
Sort By:
Page
of 13
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
July 16, 2010
Activation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor β2 in cancer cells
Youzhong Wan, Maojing Yang, Sunny Kolattukudy, et al.
The Journal of Biological Chemistry
|
November 4, 2004
Role of tyrosine 441 of interferon-gamma receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation
Yulan Qing, Ana P Costa-Pereira, Diane Watling, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 20, 2021
PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance to DNA damage
HyeonJoo Cheon, Elise G Holvey-Bates, Daniel J McGrail, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2002
IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA
Kristi L Peters, Heather L Smith, George R Stark, et al.
Trends in Immunology
|
April 4, 2002
Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling
Chilakamarti V Ramana, M Pilar Gil, Robert D Schreiber, et al.
Cancer Research
|
October 19, 2007
p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21
Charlene E Kan, John T Patton, George R Stark, et al.
Immunity
|
September 19, 2006
Complex modulation of cell type-specific signaling in response to type I interferons
Anette H H van Boxel-Dezaire, M R Sandhya Rani, George R Stark
Trends in Cancer
|
October 10, 2022
How cancer cells make and respond to interferon-I
HyeonJoo Cheon, Yuxin Wang, Samantha M Wightman, et al.
The EMBO Journal
|
November 18, 2016
Negative regulation of type I IFN signaling by phosphorylation of STAT2 on T387
Yuxin Wang, Jing Nan, Belinda Willard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2021
The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage
Sarmishtha De, Elise G Holvey-Bates, Kala Mahen, et al.
Page
of 13